News

Article

FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-Mutated Non-Small Cell Lung Cancer

For more information, read the FDA announcement and visit the Daiichi Sankyo website.

For more information, read the FDA announcement and visit the Daiichi Sankyo website.